We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
(-6.1%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$352M |
| 2 |
Kroger
KR
|
+$279M |
| 3 |
AT&T
T
|
+$235M |
| 4 |
Intel
INTC
|
+$217M |
| 5 |
Edwards Lifesciences
EW
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Merck
MRK
|
+$459M |
| 3 |
Coca-Cola
KO
|
+$295M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$283M |
| 5 |
TSMC
TSM
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.08% |
| 2 | Technology | 16.14% |
| 3 | Healthcare | 15.45% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Consumer Staples | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHQA
901
DELISTED
Shelter Acquisition Corporation I Class A Common Stock
SHQA
| $9.64M | 0.02% |
973,498
| – | – |
|
|
VRN
902
DELISTED
Veren
VRN
| $9.61M | 0.02% |
1,560,233
-578,993
| -27% | -$4.13M |
|
903
Amylyx Pharmaceuticals
AMLX
$2.05B
| $9.6M | 0.02% |
341,064
-317,309
| -48% | -$7.92M |
|
904
M/I Homes
MHO
$3.83B
| $9.58M | 0.02% |
264,324
+218,561
| +478% | +$9.44M |
|
|
TRIS
905
DELISTED
Tristar Acquisition I Corp.
TRIS
| $9.54M | 0.02% |
962,403
| – | – |
|
906
KB Financial Group
KB
$41.2B
| $9.53M | 0.02% |
+316,139
| New | +$11.4M |
|
|
BRD
907
DELISTED
Beard Energy Transition Acquisition Corp.
BRD
| $9.52M | 0.02% |
950,000
| – | – |
|
|
AERT
908
Aeries Technology
AERT
$37.7M
| $9.52M | 0.02% |
118,974
| – | – |
|
|
INFN
909
DELISTED
Infinera Corporation Common Stock
INFN
| $9.51M | 0.02% |
1,965,359
-489,186
| -20% | -$2.68M |
|
|
910
PUT
UnitedHealth
UNH
$382B
| $9.51M | 0.02% |
+18,800
| New | +$9.89M |
|
911
CALL
Citigroup
C
$222B
| $9.49M | 0.02% |
227,700
+207,500
| +1,027% | +$10.3M |
|
|
DISH
912
DELISTED
DISH Network Corp.
DISH
| $9.47M | 0.02% |
684,818
+636,018
| +1,303% | +$11.2M |
|
913
iShares Russell 2000 ETF
IWM
$79.8B
| $9.45M | 0.02% |
+57,282
| New | +$10.4M |
|
|
IIII
914
DELISTED
INSU Acquisition Corp. III Class A Common Stock
IIII
| $9.43M | 0.02% |
946,933
| – | – |
|
915
ZTO Express
ZTO
$18.2B
| $9.43M | 0.02% |
392,377
-1,129,199
| -74% | -$29.4M |
|
916
Robinhood
HOOD
$85.2B
| $9.43M | 0.02% |
933,107
-347,262
| -27% | -$3.34M |
|
917
CALL
Broadcom
AVGO
$1.82T
| $9.41M | 0.02% |
212,000
+208,000
| +5,200% | +$10.6M |
|
918
ASE Group
ASX
$80.8B
| $9.4M | 0.02% |
1,884,192
+1,856,825
| +6,785% | +$10.5M |
|
919
DaVita
DVA
$15.1B
| $9.38M | 0.02% |
+113,363
| New | +$9.94M |
|
920
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.35B
| $9.37M | 0.02% |
345,800
+344,400
| +24,600% | +$10.6M |
|
|
THCP
921
DELISTED
Thunder Bridge Capital Partners IV, Inc. Class A Common Stock
THCP
| $9.35M | 0.02% |
961,111
| – | – |
|
922
PUT
Qualcomm
QCOM
$176B
| $9.34M | 0.02% |
82,700
+81,000
| +4,765% | +$11.1M |
|
923
Banzai International
BNZI
$7.29M
| $9.34M | 0.02% |
94
| – | – |
|
924
Tenable Holdings
TENB
$3.56B
| $9.33M | 0.02% |
268,214
-190,564
| -42% | -$7.99M |
|
925
ExxonMobil
XOM
$651B
| $9.33M | 0.02% |
+106,883
| New | +$9.76M |
|
Similar funds
Marshall Wace's Q3 2022 Portfolio in Review
As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.
- Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
- Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
- Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
- Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
- Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
- Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
- Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.